Pfizer CRZ 250 (Xalkori 250 mg)

Generic Name: crizotinib

Pill imprint Pfizer CRZ 250 has been identified as Xalkori 250 mg.

Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for Pfizer CRZ 250 (Xalkori 250 mg)

Xalkori
Generic Name:
crizotinib
Imprint:
Pfizer
CRZ 250
Strength:
250 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)